Business Wire

Mary Kay Inc. Named Among Most Reputable Global Employers in Reputation Institute’s 2019 Workplace Study

29.7.2019 18:00:00 EEST | Business Wire | Press release

Share

Mary Kay Inc. is proud to be recognized in the 2019 Global Workplace 100 Study by Reputation Institute (Ri) as one of the world’s most reputable employers. Mary Kay is ranked number 42 among the top 100 global companies on the list.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190729005477/en/

“Our reputation among employees and customers is based on the foundation Mary Kay Ash established when she began her dream company in 1963,” said Melinda Foster Sellers, Chief People Officer at Mary Kay Inc. “She envisioned a company based on the Golden Rule that made the world a better place through corporate responsibility, innovation, ethical business practices and people-first management—all factors that contributed to our success in this year’s Reputation Institute study. We’re honored to be named among the most reputable employers from around the world in 2019.”

In the study, researchers at Reputation Institute—a leading provider of reputation measurement and management services—surveyed more than 230,000 individuals in 15 countries. Reputation Institute measured companies based on professional development, total rewards, work environment, market leadership, products and responsibility.

According to the research, over the last year, willingness to work for Mary Kay increased by 6.2 percent, the largest improvement among all the companies measured in the Global RepTrak® 100 study. Mary Kay outranks other global powerhouse brands in a variety of industries across the globe.

“Mary Kay is a rising star in the reputation study—showing the biggest improvement in the ‘willingness to work for’ category of all companies measured,” said Stephen Hahn-Griffiths, Chief Reputation Officer at Ri. “Companies like Mary Kay are reaping the benefits of building workplace cultures that foster inclusion while demonstrating concern for the health and well-being of its employees.”

This is the latest in the series of accolades Mary Kay has received highlighting its position as a global employer of choice. Other recent awards include:

  • Top 10 Global CEOs: Reputation Institute named Chairman and CEO David Holl among the top 10 most reputable chief executives in the world according to its CEO RepTrak® 2019.
  • Best Midsize Employer 2019: Recognized by Forbes as one of America’s Best Midsize Employers 2019. Mary Kay is ranked number 97 of the 500 companies on the list.
  • Best Employer for Diversity 2019: Recognized by Forbes as one of America’s Best Employers for Diversity 2019. Mary Kay is ranked number 150 of the 500 companies on the list.
  • Global Excellence in the Workplace: Mary Kay Spain and Mary Kay Poland earned the 2018 AON Best Employers Award, recognizing organizations demonstrating excellence in the workplace. Mary Kay China and Mary Kay Mexico picked up the honor in 2017.
  • Family-Friendly Employer 2018: Mary Kay Hong Kong was recognized by Home Affairs Bureau as a top family-friendly employer.
  • Chinese Enterprise Health Management Top 10 Employers 2018: China International Intellectech Corporation honored Mary Kay China.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, provide irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through The Mary Kay FoundationSM, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive

emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release

emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead

Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release

Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme

EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release

European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea

ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release

ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye